Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

EMEA accepts Schering's corifollitropin alfa submission for review

Jan. 7, 2009

FDA advises NMRC not to initiate clinical trial of Biopure's Hemopure

Jan. 7, 2009

VIA licenses drug candidates from Roche for metabolic disease

Jan. 7, 2009

FDA accepts for filing Northfield Laboratories' BLA for PolyHeme

Jan. 5, 2009

Savient's pegloticase BLA for treatment-failure gout granted priority review

Jan. 5, 2009

Biocompatibles and AstraZeneca sign agreements for GLP-1 analogue

Jan. 5, 2009

NPS commences phase III REPLACE study for NPSP-558 in hypoparathyroidism

Dec. 31, 2008

AMAG receives complete response letter from FDA for ferumoxytol in kidney disease

Dec. 31, 2008

Additional indication for Fastic/Starsis approved in Japan

Dec. 30, 2008

Wyeth acquires Thiakis and obesity drug TKS-1225

Dec. 30, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...